FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W95742403> ?p ?o ?g. }

• W95742403 endingPage "281" @default.
• W95742403 startingPage "278" @default.
• W95742403 abstract "Thrombosis is the most frequent complication and the second cause of death in patients with overt malignant diseases. Increasing evidence suggests that thrombotic episodes may also precede the diagnosis of cancer by months or years thus representing a potential marker for occult malignancy. Recently, emphasis has been given to the potential risk of cancer therapy (both surgery and chemotherapy) in enhancing the risk for thromboembolic disease. Post-operative deep-vein thrombosis is indeed more frequent in patients operated for malignant diseases than for other disorders. On the other hand, both chemotherapy and hormone therapy are associated with an increased thrombotic risk, which can be prevented by low-dose oral anticoagulation. Possible contributory causes for thromboembolic disease in cancer include the capacity of tumor cells and their products to interact with platelets, clotting and fibrinolytic systems, as well as their interactions with endothelial cells and tumor-associated macrophages. In particular, procoagulant activities of tumor cells have been extensively studied; one of these, cancer procoagulant, could represent a novel marker of malignancy in both solid tumors and acute promyelocytic leukemia (APL). In solid tumors, CP, a vitamin K dependent enzyme could represent the selective target of the antimetastatic effects of warfarin treatment. In APL, CP may contribute to trigger the well known intravascular coagulation syndrome accompanying the early manifestations of the disease and is depressed by all-trans-retinoic acid, an agent capable to determine complete remission with a rapid amelioration of the bleeding syndrome.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
• W95742403 created "2016-06-24" @default.
• W95742403 creator A5033370052 @default.
• W95742403 date "1995-01-01" @default.
• W95742403 modified "2023-10-17" @default.
• W95742403 title "Cancer and Thrombosis: from Phlegmasia Alba Dolens to Transgenic Mice" @default.
• W95742403 cites W1521872460 @default.
• W95742403 cites W1575875297 @default.
• W95742403 cites W174924583 @default.
• W95742403 cites W1788588662 @default.
• W95742403 cites W1963150823 @default.
• W95742403 cites W1967832446 @default.
• W95742403 cites W2009225170 @default.
• W95742403 cites W2014233119 @default.
• W95742403 cites W2015470697 @default.
• W95742403 cites W2065710794 @default.
• W95742403 cites W2076642163 @default.
• W95742403 cites W2093179894 @default.
• W95742403 cites W2100184560 @default.
• W95742403 cites W2111439385 @default.
• W95742403 cites W2125767003 @default.
• W95742403 cites W2142272071 @default.
• W95742403 cites W2155647570 @default.
• W95742403 cites W2167661845 @default.
• W95742403 cites W2328710175 @default.
• W95742403 cites W2406995304 @default.
• W95742403 cites W2408832512 @default.
• W95742403 cites W2410246461 @default.
• W95742403 cites W2413612554 @default.
• W95742403 cites W2415970497 @default.
• W95742403 cites W2418999768 @default.
• W95742403 cites W2421107533 @default.
• W95742403 cites W2430155638 @default.
• W95742403 doi "https://doi.org/10.1055/s-0038-1642690" @default.
• W95742403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8578472" @default.
• W95742403 hasPublicationYear "1995" @default.
• W95742403 type Work @default.
• W95742403 sameAs 95742403 @default.
• W95742403 citedByCount "117" @default.
• W95742403 countsByYear W957424032012 @default.
• W95742403 countsByYear W957424032013 @default.
• W95742403 countsByYear W957424032014 @default.
• W95742403 countsByYear W957424032015 @default.
• W95742403 countsByYear W957424032016 @default.
• W95742403 countsByYear W957424032017 @default.
• W95742403 countsByYear W957424032018 @default.
• W95742403 countsByYear W957424032019 @default.
• W95742403 countsByYear W957424032021 @default.
• W95742403 countsByYear W957424032022 @default.
• W95742403 countsByYear W957424032023 @default.
• W95742403 crossrefType "journal-article" @default.
• W95742403 hasAuthorship W95742403A5033370052 @default.
• W95742403 hasConcept C104317684 @default.
• W95742403 hasConcept C121608353 @default.
• W95742403 hasConcept C126322002 @default.
• W95742403 hasConcept C142724271 @default.
• W95742403 hasConcept C143998085 @default.
• W95742403 hasConcept C185592680 @default.
• W95742403 hasConcept C203014093 @default.
• W95742403 hasConcept C2776301958 @default.
• W95742403 hasConcept C2776601000 @default.
• W95742403 hasConcept C2776694085 @default.
• W95742403 hasConcept C2778734968 @default.
• W95742403 hasConcept C2778959117 @default.
• W95742403 hasConcept C2779134260 @default.
• W95742403 hasConcept C2779161974 @default.
• W95742403 hasConcept C2779399171 @default.
• W95742403 hasConcept C2780868729 @default.
• W95742403 hasConcept C2781121885 @default.
• W95742403 hasConcept C55493867 @default.
• W95742403 hasConcept C71924100 @default.
• W95742403 hasConcept C81182388 @default.
• W95742403 hasConcept C90924648 @default.
• W95742403 hasConceptScore W95742403C104317684 @default.
• W95742403 hasConceptScore W95742403C121608353 @default.
• W95742403 hasConceptScore W95742403C126322002 @default.
• W95742403 hasConceptScore W95742403C142724271 @default.
• W95742403 hasConceptScore W95742403C143998085 @default.
• W95742403 hasConceptScore W95742403C185592680 @default.
• W95742403 hasConceptScore W95742403C203014093 @default.
• W95742403 hasConceptScore W95742403C2776301958 @default.
• W95742403 hasConceptScore W95742403C2776601000 @default.
• W95742403 hasConceptScore W95742403C2776694085 @default.
• W95742403 hasConceptScore W95742403C2778734968 @default.
• W95742403 hasConceptScore W95742403C2778959117 @default.
• W95742403 hasConceptScore W95742403C2779134260 @default.
• W95742403 hasConceptScore W95742403C2779161974 @default.
• W95742403 hasConceptScore W95742403C2779399171 @default.
• W95742403 hasConceptScore W95742403C2780868729 @default.
• W95742403 hasConceptScore W95742403C2781121885 @default.
• W95742403 hasConceptScore W95742403C55493867 @default.
• W95742403 hasConceptScore W95742403C71924100 @default.
• W95742403 hasConceptScore W95742403C81182388 @default.
• W95742403 hasConceptScore W95742403C90924648 @default.
• W95742403 hasIssue "01" @default.
• W95742403 hasLocation W957424031 @default.
• W95742403 hasLocation W957424032 @default.
• W95742403 hasOpenAccess W95742403 @default.

• next